Skip to main content
MEDIKIT CO.,LTD logo

MEDIKIT CO.,LTD — Investor Relations & Filings

Ticker · 7749 ISIN · JP3921060004 T Manufacturing
Open in API
Filings indexed 65 across all filing types
Latest filing 2025-12-01 Transaction in Own Shar…
Country JP Japan
Listing T 7749

About MEDIKIT CO.,LTD

http://medikit.co.jp/english/

MEDIKIT CO., LTD. is a medical device company that develops, manufactures, and sells medical equipment, with a primary focus on vascular access devices. The company's main product lines include intravenous (IV) safety catheters and hemodialysis (HD) catheters, particularly those utilizing fluorine resin. Its portfolio also encompasses artificial dialysis equipment and related components. MEDIKIT's product development philosophy emphasizes minimal invasiveness, user safety for healthcare professionals, and patient comfort during medical procedures.

Recent filings

Filing Released Lang Actions
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares Classification · 100% confidence The document is a '自己株券買付状況報告書' (Report on Status of Acquisition of Treasury Shares) filed under Article 24-6, Paragraph 1 of the Financial Instruments and Exchange Act of Japan. It details the company's share buyback activity for the period of November 2025. This specific regulatory filing type corresponds to the 'Transaction in Own Shares' (POS) category, as it reports the company's repurchase of its own shares.
2025-12-01 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is titled '確認書' (Confirmation Letter) and explicitly cites '金融商品取引法第24条の５の２第１項' (Article 24-5-2, Paragraph 1 of the Financial Instruments and Exchange Act). It serves as an officer certification regarding the accuracy of a semi-annual report. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type. H1 43
2025-11-13 Japanese
半期報告書－第43期(2025/04/01－2026/03/31)
Interim / Quarterly Report Classification · 100% confidence The document is a '半期報告書' (Semi-Annual Report) filed under Article 24-5, Paragraph 1 of the Financial Instruments and Exchange Act of Japan. It contains comprehensive financial statements, including the balance sheet, income statement, and cash flow analysis for the interim period (April 1, 2025, to September 30, 2025). As it is a formal, comprehensive financial report for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. H1 2026
2025-11-13 Japanese
臨時報告書
AGM Information Classification · 100% confidence The document is titled "臨時報告書" (Extraordinary Report/Timely Disclosure Report) and is filed with the Kanto Local Finance Bureau. Section 1 explicitly states the reason for filing: decisions made at the Annual General Meeting (定時株主総会) held on June 26, 2025, pursuant to the Financial Instruments and Exchange Act. Section 2 details the resolutions, which include the approval of the dividend distribution (剰余金処分) and the election of directors and an auditor. This content—reporting the results of a shareholder meeting—perfectly matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). Although it relates to an AGM, the core purpose is reporting the *results* of the vote, not providing the proxy materials (PSI) or the AGM presentation itself (AGM-R).
2025-07-01 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is titled '確認書' (Confirmation Letter) and explicitly states it is filed under the Financial Instruments and Exchange Act Article 24-4-2. It serves as an officer certification regarding the accuracy of the company's Annual Securities Report (有価証券報告書). According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type. FY 2025
2025-06-25 Japanese
内部統制報告書－第42期(2024/04/01－2025/03/31)
Governance Information Classification · 100% confidence The document is titled "内部統制報告書" (Internal Control Report) and explicitly cites the legal basis as "金融商品取引法第24条の４の４第１項" (Article 24-4-4, Paragraph 1 of the Financial Instruments and Exchange Act). This structure and content—detailing the framework, scope, procedures, and conclusion regarding the effectiveness of internal controls over financial reporting as of a specific fiscal year-end (March 31, 2025)—is characteristic of the Japanese equivalent of the Sarbanes-Oxley Section 404 report, which is a mandatory annual filing. While the provided definitions do not have a direct equivalent for the Japanese 'Internal Control Report' (J-SOX), the closest functional and regulatory category among the choices is the Annual Report (10-K), as this report is intrinsically linked to the annual financial reporting cycle and is often filed concurrently or as part of the annual disclosure package. However, given the specific focus solely on internal controls, and the lack of a dedicated 'Internal Control Report' code, we must evaluate the provided options. * It is not an Earnings Release (ER) or Interim Report (IR) as it is an annual control assessment. * It is not an Audit Report (AR), although it relates to auditing standards, it is management's assertion. * It is not a Proxy Statement (DEF 14A) or AGM material. The most appropriate classification, considering the comprehensive annual nature of the control assessment required by law, aligns best with the scope of the Annual Report (10-K), which mandates this disclosure in many jurisdictions. In the context of Japanese filings, this document is a mandatory component of the annual disclosure package. However, looking closely at the definitions, 'Audit Report / Information (AR)' is defined as 'Standalone audit reports, applied accounting principles, and results of internal or regulatory stress tests (excluding full Annual Reports)'. Since this is management's report on internal controls, not an external auditor's opinion, AR is not perfect. Given the options, and recognizing this is a core component of the annual disclosure cycle, 10-K remains the closest fit for a comprehensive annual regulatory filing focused on financial integrity, even if it's a specific sub-report. Revisiting the definitions: None perfectly match the Japanese Internal Control Report. If we must choose the best fit for a comprehensive, annual, regulatory filing concerning financial integrity, 10-K is the standard proxy for the main annual filing. If the document were merely an announcement of this report, RPA would apply, but this text contains the substance of the report itself. Therefore, 10-K is selected as the best available proxy for a major annual financial integrity filing.
2025-06-25 Japanese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.